Results 131 to 140 of about 207,909 (303)

University of Medicine and Dentistry of New Jersey and Housestaff Organization of the College of Medicine and Dentistry of New Jersey (1999) [PDF]

, 1999

core   +1 more source

Policy Networks and Policy Entrepreneurship in the EU: Explaining Structural Policy Change in Pharmaceutical Innovation Incentives and Health Technology Assessment

European Policy Analysis, EarlyView.
ABSTRACT Policy process research has excelled in explaining structural policy change within national settings, but extensions and applications to the EU level have long proven challenging for scholars. Given that the EU is currently experiencing its longest period of Treaty stability since the 1980s—having evolved into a sui generis political system ...
Vassilis Karokis‐Mavrikos
wiley   +1 more source

Using QIP-MS to Guide the Timing of MRD Testing in Patients With Multiple Myeloma: A Budget Impact Analysis From the French Payer Perspective

ClinicoEconomics and Outcomes Research
Christian Siegfried,1 Miyuru Amarapala,1 Xavier Leleu,2 Lauren Fusfeld1 1Veranex, Boston, MA, USA; 2Department of Hematology, CHU, Poitiers, Poitiers, FranceCorrespondence: Christian Siegfried, CRO and Consulting Services, Veranex, 100 Federal St Suite ...
Siegfried C, Amarapala M, Leleu X, Fusfeld L   +3 more
doaj  

Trends in Medicare and Medicaid Reimbursement for Total Wrist Arthrodesis. [PDF]

Hand (N Y)
Henderson AP, Keime WK, Kumar J, Murray PM, Aziz KT.   +4 more
europepmc   +1 more source

State variation in medicaid reimbursements for orthopaedic surgery [PDF]

, 2018
Dy, Christopher J, Lalezari, Ramin M, Pozen, Alexis   +2 more
core   +1 more source

Freedon study: Real‐life outcomes of cenobamate in different lines of treatment

Epilepsia, EarlyView.
Abstract Objectives Cenobamate is an antiseizure medication (ASM) with proven effectiveness in individuals with highly refractory epilepsy. This study investigated the effectiveness and tolerability of cenobamate in different treatment lines and a less refractory setting. Methods This was a multicenter, retrospective, observational study.
Vicente Villanueva, José María Serratosa, Alejandro Fernández‐Cabrera, Manuel Toledo, Beatriz González‐Giráldez, José C. Estevez, Juan Jesús Rodríguez Uranga, Maria Machio Castelló, Maria Dolores Castro‐Vilanova, Juan José Poza, Xiana Rodríguez‐Osorio, Kevin G. Hampel, Elena Fonseca, Francisco Javier López‐González, Mercedes Garcés, Laura Abraira, Jordi Ciurans, Daniel Campos‐Fernández, Estevo Santamarina, Juan María Sanchez‐Caro, Lucas Iacampo, Julia Renau, Miguel Ángel García‐Quesada, Carla Anciones, María Isabel Chamorro, Iratxe Maestro, Pablo Cabezudo, Raquel Calle, Jesús Macarron, Beatriz Cabezas, María Carrasco, María López, Marta Marín, Rosa Querol, Belén Baena, Vanessa García‐Morales, Samuel López‐Maza, Álvaro Juiz, Blanca Mercedes‐Alvarez, Carla Amarante, Ana del Villar, Ascensión Castillo, Marta Rubio‐Roy, Javier Martinez‐Poles, Asier Gómez‐Ibáñez, Beatriz Parejo‐Carbonell, Anabelén Martínez Garcia, Ignacio Carrera, Pablo Iriarte, Fátima Romero‐Aguilera, on behalf of the Pharmacological Therapy Working group of the Spanish Epilepsy Society and Freedon Group   +50 more
wiley   +1 more source

Mystery Shopper: Antibiotics for sale at flea markets in a Mexican urban area. [PDF]

Farm Comunitarios
Morales Rojas ME, Aké Canul DF, Uicab Cauich JE, Cohuo Cob SM.   +3 more
europepmc   +1 more source

Three Village Central School District and Clerical Unit, United Public Service Employees Union (2001) [PDF]

, 2001

core   +1 more source

Stiripentol: Unpublished results from the first phase 2 clinical trial in Lennox–Gastaut syndrome conducted in the early 1990s

Epilepsia, EarlyView.
Abstract Objective This study was undertaken to present the results of an exploratory phase 2 trial of stiripentol in Lennox–Gastaut syndrome (LGS). Methods This exploratory single‐blind, single‐arm, nonrandomized sequential‐period phase 2 study was conducted at four centers in France between January 1989 and August 1993.
Stéphane Auvin, Benjamin Serraz, Jérémie Lespinasse, Laurent Chancharme   +3 more
wiley   +1 more source

Do what is needed; bill for it* (a Halloween hot take). [PDF]

Can Urol Assoc J
Leveridge M.
europepmc   +1 more source